A Netweekly Story Stock Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : A Netweekly Story Stock

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Postman who wrote (6)	3/1/1999 12:40:00 PM
From: Tom Latham	Read Replies (1) of 15

Undervalued, Underfollowed, and totally misunderstood. ASCT (ASENT PEDIATRICS) trended from over 4 to well over 7 on takeover speculation. When the "takeover" came out as an infusion of cash(12mil) and subordinated note (28 mil) to enhance the growth of the company, ------The bubble burst as those that had just gotten in were looking for 10 so they exited. Look at the chart, 50d BB bottoms at 2 5/16. 50d MA pegs @ 4 1/4 50d BB top tracks @ 6 Vol is ultra thin Float 1.7 mil shares The suitor ALO (ALPHARMA) has acknowledged that a pure buyout may happen. The company (ASCT) now should gather momentum and get back to the 50d MA of 4 1/4 then trend to the top band of 6 without the buyout consideration just in their business aspect alone. My 30 day target on ASCT is 6 (a double), 90 day target is 8-10. ALPHARMA is not commiting 40 million dollars and holding the option to buy a company that doesn't have a bright future.... They know much more than is in the print.... Your DD and you should see......

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next